Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
+0.10 (0.32%)
Apr 29, 2026, 1:30 PM CST

Taiyen Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
1,3491,5511,4451,5291,726
Upgrade
Short-Term Investments
11.4140.314.24-1.06
Upgrade
Trading Asset Securities
384.99346.32390.61353.18353.54
Upgrade
Cash & Short-Term Investments
1,7461,9381,8401,8822,080
Upgrade
Cash Growth
-9.92%5.35%-2.27%-9.52%10.15%
Upgrade
Accounts Receivable
524.03498.3663.23650.28757.6
Upgrade
Other Receivables
9.686.2323.4332.787.19
Upgrade
Receivables
533.71504.53686.66683.06764.79
Upgrade
Inventory
376.81427.32394.74407.37395.02
Upgrade
Other Current Assets
99.9457.64105.27121.26154.52
Upgrade
Total Current Assets
2,7562,9273,0263,0943,395
Upgrade
Property, Plant & Equipment
4,1194,0233,9053,7133,564
Upgrade
Long-Term Investments
40.9840.9733.96--
Upgrade
Other Intangible Assets
10.1711.716.415.348.53
Upgrade
Long-Term Deferred Tax Assets
57.0363.6581.972.1287.22
Upgrade
Other Long-Term Assets
1,2791,3151,2661,3271,413
Upgrade
Total Assets
8,2638,3818,3208,2128,468
Upgrade
Accounts Payable
329.32419.51384.5399.06485.3
Upgrade
Short-Term Debt
869810020287.53
Upgrade
Current Portion of Long-Term Debt
5.5666.9515.318.654.29
Upgrade
Current Portion of Leases
7.418.767.269.2710.76
Upgrade
Current Income Taxes Payable
52.0243.3666.2942.1779.75
Upgrade
Current Unearned Revenue
70.19109.7698.03102.2379.02
Upgrade
Other Current Liabilities
409.4418.81429.62344.67358.74
Upgrade
Total Current Liabilities
959.891,1651,101926.051,305
Upgrade
Long-Term Debt
-5.5672.568.9353.08
Upgrade
Long-Term Leases
26.5625.9325.0928.5936.33
Upgrade
Long-Term Unearned Revenue
284.66297.72307.19320.05332.92
Upgrade
Pension & Post-Retirement Benefits
3.1737.6894.0462.39108.81
Upgrade
Long-Term Deferred Tax Liabilities
35.339.4434.3834.2334.08
Upgrade
Other Long-Term Liabilities
139.22142.08136.68109.5283.67
Upgrade
Total Liabilities
1,4491,7141,7711,5501,954
Upgrade
Common Stock
2,0002,0002,0002,0002,000
Upgrade
Additional Paid-In Capital
2,4912,5022,5022,5022,502
Upgrade
Retained Earnings
2,3252,1651,9932,0221,862
Upgrade
Comprehensive Income & Other
-2.39-2.63-3.38-2.99-2.16
Upgrade
Total Common Equity
6,8146,6646,4916,5216,361
Upgrade
Minority Interest
-3.5357.6140.69152.2
Upgrade
Shareholders' Equity
6,8146,6686,5496,6626,513
Upgrade
Total Liabilities & Equity
8,2638,3818,3208,2128,468
Upgrade
Total Debt
125.52205.2220.17135.44391.98
Upgrade
Net Cash (Debt)
1,6201,7331,6191,7471,688
Upgrade
Net Cash Growth
-6.49%7.00%-7.29%3.46%0.42%
Upgrade
Net Cash Per Share
8.078.648.088.718.42
Upgrade
Filing Date Shares Outstanding
200200200200200
Upgrade
Total Common Shares Outstanding
200200200200200
Upgrade
Working Capital
1,7961,7621,9252,1682,089
Upgrade
Book Value Per Share
34.0733.3232.4632.6131.81
Upgrade
Tangible Book Value
6,8046,6526,4856,5166,353
Upgrade
Tangible Book Value Per Share
34.0233.2632.4232.5831.76
Upgrade
Land
1,8161,8161,8161,8161,736
Upgrade
Buildings
1,6541,5681,4231,3541,322
Upgrade
Machinery
3,6403,5073,0042,8372,844
Upgrade
Construction In Progress
79.36186.56632.49440.46323.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.